Boston, MA, November 16, 2015 --(PR.com
)-- World Congress has announced the agenda and speakers for the 2nd Annual Biosimilars Market Access Summit. The event will take place February 23-24 in Washington, D.C. The 2016 theme is “Design a Successful Commercial Strategy for Entry into the U.S. Biosimilars Market by Ensuring Appropriate Pricing, Education and Value Proposition to Customers” and will feature an innovative line up of presenters from leading companies including, Boehringer Ingelheim, Merck Serono and others. Perspectives from the FTC, patient advocates, and a former representative of the FDA will enhance the conversation by providing out-of-industry considerations that directly impact your market access strategy.
2016 Key Topics include:
· Pricing and reimbursement trends to best prepare for product launch
· Lessons from more developed biosimilar markets
· Effective means of educating the market on the value of biosimilars
· Clarity on the legal and regulatory landscape
To view the full agenda and speaker line-up, please download the brochure: http://bit.ly/1P9SiND.
This Summit is a must-attend for biosimilar manufacturers who want to share best practices and ideas on how to successfully bring these products to market in the U.S. Visit www.worldcongress.com/biosimilars to register.
World Congress provides thought-provoking, timely consulting, research, and advisory services to advance the health care and life sciences industries. Through our educationally focused events, we convene CEOs and senior-level executives from all segments of the health care and life sciences industries to exchange ideas, discuss market trends, and explore solutions to the most pressing challenges facing a variety of roles within these organizations. www.worldcongress.com